Rasio Total Utang marang Ekuitas Absci Corp (ABSI)

ABSI (Absci Corporation) - tandha merek perusahaan

Absci (ABSI) designs unique antibodies using generative AI, which radically reduces laboratory testing costs. The company's operations are not subject to seasonality, although financial stability is tied to venture capital. The share price history on GURU.Markets demonstrates the 0.02 metric, while potential profit growth is constrained by significant software development costs.

ABSI Rasio Kabeh Utang marang Dana Pribadi Absci Corporation (04.07.2022 - 27.10.2026)

Rincian analitis lan laporan data perusahaan Absci Bio (ABSI)

- rega lan prakiraan konsensus rega:
Rega saham Absci Corporation|ABSI - Target median analis
- data kapitalisasi pasar:
Biji pasar Absci|ABSI - Total Nilai Bisnis
- data kapitalisasi buku:
Nilai Akuntansi saben Saham Absci|ABSI - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku absci.com|ABSI - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Absci|ABSI - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Absci|ABSI - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Absci
Analisis dhasar perusahaan:Absci Corporation, ABSI
Sampel barang Absci Bio

For Absci (ABSI), financial stability is determined by the balance between borrowed funds and equity assets. By analyzing the total debt-to-equity ratio, an investor assesses the degree of leverage within the capital structure. This metric aggregates all liabilities, weighing them against the company's net worth. For this AI-drug developer, the indicator reflects the cost of scaling R&D infrastructure. The trend of this metric allows for an assessment of the business's risk of dependence on external financing while awaiting payments from pharmaceutical partners.

Pesaing utama

VEEV: Total Utang marang Modal|Koefisien Total Utang marang Modal Doximity Inc (DOCS)|Rasio Total Utang marang Ekuitas HealthEquity Corp|Utang Agregat marang Modal Waystar Corp WAY|Rasio Total Utang marang Ekuitas CorVel Corporation|priviahealth.com - Rasio Kabeh Utang marang Dana Pribadi|HURN: Utang marang Ekuitas|CERT - Rasio Total Utang marang Ekuitas|Total Utang marang Modal OMCL|GoodRx Gold (GDRX) - Utang marang Modal|Total Utang marang Modal Schrodinger, Inc. (SDGR)|Rasio Utang marang Ekuitas phreesia.com|Total Utang marang Modal OMDA|Total Utang marang Modal Evolent Health Inc (EVH)|Total Utang marang Modal HealthStream Corp HSTM|Definitive Corp - Utang marang Ekuitas|Utang marang Ekuitas CCSI (Consensus Cloud Solutions)|AGL - Koefisien Total Utang marang Modal|SY (So-Young International Inc.) - Total Utang marang Modal|National Research Corp. (NRC) - Rasio Total Utang marang Ekuitas|SPOK: Total Utang marang Modal|Koefisien Total Utang marang Modal OptimizeRx Inc.|Total Utang marang Modal TBRG|Total Utang marang Modal simulations-plus.com (SLP)|Total Utang marang Modal SOPHiA GENETICS SOPH|Health Catalyst Inc. - Utang marang Ekuitas|Utang marang Ekuitas CCLD (CareCloud Corp)|RSSS - Koefisien Total Utang marang Modal|dlhcorp.com - Total Utang marang Modal|OneMedNet (ONMD) - Koefisien Total Utang marang Modal|SCNX: Total Utang marang Modal|Koefisien Total Utang marang Modal Healthcare Triangle Inc (HCTI)|Rasio Total Utang marang Ekuitas iSpecimen Inc.|Utang Agregat marang Modal bullfrogai.com BFRG|Rasio Total Utang marang Ekuitas SCWorx Corp.|msprecovery.com - Rasio Kabeh Utang marang Dana Pribadi|ICCT: Utang marang Ekuitas|MEDS - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ORGS|R1 RCM (RCM) - Utang marang Modal|Total Utang marang Modal Sharecare, Inc. (SHCR)|Rasio Utang marang Ekuitas streamlinehealth.net|Total Utang marang Modal SYRA|Total Utang marang Modal apollomed.net (AMEH)|Total Utang marang Modal Model N Corp MODN|NextGen Healthcare Corp - Utang marang Ekuitas